The significantly down-regulated expression of RAD51 by OXY may be the key mechanism by which OXY mediates its anticancer effect in consideration of RAD51 being overexpressed in a variety of cancer cells (Raderschall et al., 2002; Hannay et al., 2007; Klein, 2008). This evidence concerns the gene RAD51 and cancer.